[Antisense oligonucleotide targeting survivin affects the proliferation and apoptosis of SMMC-7721 cells]

Kejian Pan1, Xiaojing Liu, Chunlei Yang

  • 1Division of Basic Medical Science, Chengdu Medical College, Chengdu 610083, China. pkj6696@yahoo.com.cn

Insights

Antisense oligonucleotides targeting survivin effectively reduced cancer cell proliferation and increased apoptosis. This suggests a potential for selective tumor therapy in the future.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Apoptosis Regulation

Background:

  • Survivin, an inhibitor of apoptosis (IAP) protein, is highly expressed in various human cancers but not in normal adult tissues.
  • This differential expression makes survivin a promising target for selective cancer therapies.

Purpose of the Study:

  • To design and evaluate the efficacy of a human survivin antisense oligonucleotide.
  • To assess the impact of survivin inhibition on cancer cell proliferation and apoptosis.

Main Methods:

  • Reverse Transcription Polymerase Chain Reaction (RT-PCR) and Western blot to confirm survivin mRNA and protein reduction.
  • MTT assay to measure SMMC-7721 cell proliferation inhibition.
  • Flow cytometry and TUNEL assay to quantify apoptosis rates.

Main Results:

  • The survivin antisense oligonucleotide significantly decreased survivin mRNA and protein levels in SMMC-7721 cells.
  • Cell proliferation was inhibited by 43.28% in the antisense oligonucleotide group compared to 6.76% in the control.
  • Apoptosis rates increased to 33.68% with antisense oligonucleotide treatment, significantly higher than the control group's 14.12%.

Conclusions:

  • Human survivin antisense oligonucleotides effectively inhibit cancer cell proliferation and induce apoptosis.
  • Survivin-targeted antisense oligonucleotides demonstrate potential as a selective therapeutic strategy for human cancers.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...